Get Started

ANRO

NYSE Alto Neuroscience, Inc.
Oct 30, 2026 · 9:32 PM ET EOD Market Closed

$22.60 ↑ +0.00 (+0.00%) Trading Up from the previous close of $22.60, $0.61 below the day’s high of $23.21

YTD change
+26.97%
vs 20-day SMA
-2.53%
vs 200-day SMA
-6.72%

Price ranges

Previous day
$22.92 $24.15
open $23.46 close $23.47
+$0.01 (+0.04%)
Today
$21.90 $23.21
open $23.21 now $22.60
-$0.61 (-2.63%)
Past week
$21.45 $24.15
from $22.20 now $22.60
+$0.40 (+1.80%)
Past month
$21.32 $26.10
from $25.31 now $22.60
-$2.71 (-10.71%)
This year
$13.91 $37.48
from $17.80 now $22.60
+$4.80 (+26.97%)

Price & Performance

-3.06 (-11.93%) / 6M

$16.77$23.88$31.00$38.11Apr 30Jul 31Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 39.7% away from all-time highs of $37.48
  • ANRO is up 27% since the beginning of the year
  • ANRO is up 58% over the past 12 months
  • ANRO is down 11% over the past 1 month
  • 15% of all ANRO investors are betting against ANRO
  • Number of investors short ANRO has gone up 36% versus last month

ANRO reads not so good: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +57.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.65
Earnings momentum +3.5% Quarterly EPS growth
Quarterly change +3.5%

Valuation

P/E ratio N/A
Enterprise value $784.4M
Beta 1.34

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$243.7M
Debt$23.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $923.2M

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.54 +3.19%
JNJ Johnson & Johnson $273.20 -0.73%
ABBV AbbVie, Inc. $294.89 +1.41%
MRK Merck & Co., Inc. $149.52 +2.18%
RHHBY Roche Holding Ltd Sponsored ADR $61.27 +0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.